Lobbying Information
Subject Matters
- Agriculture
- Consumer Issues
- Education
- Employment and Training
- Environment
- Fisheries
- Forestry
- Government Procurement
- Health
- Industry
- Intellectual Property
- International Trade
- Labour
- Science and Technology
- Taxation and Finance
Subject Matter Details
Legislative Proposal, Bill or Resolution
- Proposed Amendments to Canada's Food and Drugs Act (former Bill C-51) as they relate to the licencing and post-market surveillance of pharmaceuticals, consumer health products and natural health products
Policies or Program
- Consultations on Canada's taxation policies relating to scientific research and experimental development tax credits as they apply to innovative pharmaceutical companies
- Implementation of the Canada-European Union Free Trade Agreement with respect to provisions relating to intellectual property protection.
Communication Techniques
-
Written communication
-
Oral communication
Government Institutions
-
Agriculture and Agri-Food Canada (AAFC)
-
Canadian Food Inspection Agency (CFIA)
-
Employment and Social Development Canada (ESDC)
-
Environment Canada
-
Finance Canada (FIN)
-
Foreign Affairs, Trade and Development Canada
-
Health Canada (HC)
-
House of Commons
-
Industry Canada
-
Members of the House of Commons
-
Natural Resources Canada (NRCan)
-
Patented Medicine Prices Review Board (PMPRB)
-
Pest Management Regulatory Agency (PMRA)
-
Prime Minister's Office (PMO)
-
Privy Council Office (PCO)
-
Revenue Canada (RC)
-
Senate of Canada
In-house Corporation Details
Description of activities
Bayer Inc. ("Bayer") is a Canadian subsidiary of Bayer AG, an international research-based group with core businesses in health care, crop science, and innovative materials.Headquartered in Toronto, Ontario, Bayer Inc. operates the Bayer Group's HealthCare and MaterialScience businesses in Canada. Bayer CropScience Inc., headquartered in Calgary, Alberta operates as a separate legal entity in Canada. Together, the companies play a vital role in improving the quality of life for Canadians - producing products that fight diseases, protecting crops and animals, and developing high-performance materials for applications in numerous areas of daily life.
Responsible officer name and position during the period of this registration
Christian Lauterbach,
President and Chief Executive Officer
Government funding
No government funding was received during the last completed financial year.
In-house Corporation Contact Information
Address:
2920 Matheson Blvd. East
Mississauga, ON L4W 5R6
Canada
Telephone number:
905-282-5550
Parent Company Information
Subsidiary Beneficiary Information
Bayer Inc. does not have any subsidiaries that could have a direct interest in the outcome of the undertaking
Lobbyists Details
Senior Officers whose lobbying activities represent less than 20% of their Duties
- Elizabeth Beemer,
Head of Consumer Care |
No public offices held
- Mike Cels,
Head of General Medicine |
No public offices held
- Shurjeel Choudhri,
Head, Medical & Scientific Affairs |
No public offices held
- Jacqueline DeGagne,
Head - Law and Patents |
No public offices held
- Matthew Frost,
Head of Animal Health |
No public offices held
- Carmen Kisters,
Chief Financial Officer |
No public offices held
- Christian Lauterbach,
President and Chief Executive Officer |
No public offices held
- Heather McDonald,
Head of Market Access and Government Affairs |
No public offices held
- Russell Newsome,
Head of Diabetes Care |
No public offices held
- Lida Steduto,
Head, Radiology and Interventional |
No public offices held
Senior Officers and Employees whose lobbying activities represent 20% or more of their Duties
- Lisa-Marie Lefebvre,
Manager of Market Access, Quebec and Federal Affairs |
Public offices held